<p>Abdominal aortic aneurysms (AAA) and aorto-iliac occlusive disease (AIOD) are traditionally managed via open or endovascular techniques. Robotic surgery emerges as an alternative, offering enhanced visualization, precision, and ergonomics. A systematic review was conducted across PubMed, Embase, and Cochrane to identify observational studies up to September 2024. Continuous outcomes were pooled as mean values with 95% confidence intervals (CIs), and binary outcomes as proportions. Heterogeneity was assessed using the Cochrane <i>Q</i>-test and <i>I</i><sup>2</sup> statistic. Analyses were performed using R (v4.4.1). Ten studies comprising 595 patients were included. Of these, 402 (67.5%) underwent fully robotic procedures and 193 (32.5%) robotic-assisted surgery. AIOD was the primary indication in 70.5% of cases and AAA in 21.5%. Pooled operative time was 301.2&#xa0;min (95% CI 238.2–380.9), cross-clamping time 74.3&#xa0;min (95% CI 56.8–97.2), and anastomotic time 45.5&#xa0;min (95% CI 29.2–71.1). Mean blood loss was 727.5&#xa0;mL (95% CI 454.4–1164.7), and hospital stay averaged 7.3&#xa0;days (95% CI 4.8–11.0). Thirty-day mortality was 3% (95% CI 0%–5%), prosthesis patency at 12&#xa0;weeks was 92% (95% CI 82%–97%), mesenteric ischemia occurred in 5% (95% CI 2%–11%), and conversion to open surgery in 5% (95% CI 2%–8%). Subgroup analysis revealed higher cross-clamping time and blood loss in AAA compared to AIOD. Robotic aortic surgery demonstrates acceptable short-term outcomes in AAA and AIOD, with low morbidity and promising technical feasibility. Further studies with long-term follow-up are needed to validate its role in aortic surgery. </p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Robotic surgery in abdominal aortoiliac aneurysm and occlusive disease: a systematic review and single-arm meta-analysis

  • Ana Carolina Bueno Santana,
  • Lucas Monteiro Delgado,
  • Lucas Soares de Souza Pinto Guedes,
  • Bruna Maffei Bossi,
  • Pedro Henrique Coelho de Melo Leite,
  • Bernardo Fontel Pompeu

摘要

Abdominal aortic aneurysms (AAA) and aorto-iliac occlusive disease (AIOD) are traditionally managed via open or endovascular techniques. Robotic surgery emerges as an alternative, offering enhanced visualization, precision, and ergonomics. A systematic review was conducted across PubMed, Embase, and Cochrane to identify observational studies up to September 2024. Continuous outcomes were pooled as mean values with 95% confidence intervals (CIs), and binary outcomes as proportions. Heterogeneity was assessed using the Cochrane Q-test and I2 statistic. Analyses were performed using R (v4.4.1). Ten studies comprising 595 patients were included. Of these, 402 (67.5%) underwent fully robotic procedures and 193 (32.5%) robotic-assisted surgery. AIOD was the primary indication in 70.5% of cases and AAA in 21.5%. Pooled operative time was 301.2 min (95% CI 238.2–380.9), cross-clamping time 74.3 min (95% CI 56.8–97.2), and anastomotic time 45.5 min (95% CI 29.2–71.1). Mean blood loss was 727.5 mL (95% CI 454.4–1164.7), and hospital stay averaged 7.3 days (95% CI 4.8–11.0). Thirty-day mortality was 3% (95% CI 0%–5%), prosthesis patency at 12 weeks was 92% (95% CI 82%–97%), mesenteric ischemia occurred in 5% (95% CI 2%–11%), and conversion to open surgery in 5% (95% CI 2%–8%). Subgroup analysis revealed higher cross-clamping time and blood loss in AAA compared to AIOD. Robotic aortic surgery demonstrates acceptable short-term outcomes in AAA and AIOD, with low morbidity and promising technical feasibility. Further studies with long-term follow-up are needed to validate its role in aortic surgery.